Total submissions: 22
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000076774 | SCV000107813 | likely benign | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | Multifactorial likelihood analysis posterior probability 0.001-0.049 |
Gene |
RCV000192476 | SCV000170333 | benign | not specified | 2014-01-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000126809 | SCV000212787 | likely benign | Hereditary cancer-predisposing syndrome | 2014-06-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genetic Services Laboratory, |
RCV000192476 | SCV000248075 | benign | not specified | 2019-02-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001079823 | SCV000252657 | benign | Hereditary nonpolyposis colorectal neoplasms | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000192476 | SCV000303168 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000613302 | SCV000430920 | likely benign | Lynch syndrome 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Color Diagnostics, |
RCV000126809 | SCV000685147 | benign | Hereditary cancer-predisposing syndrome | 2015-04-07 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000613302 | SCV000744272 | likely benign | Lynch syndrome 1 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000656570 | SCV001158687 | benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000192476 | SCV002552215 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000613302 | SCV004015951 | likely benign | Lynch syndrome 1 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000126809 | SCV004228083 | benign | Hereditary cancer-predisposing syndrome | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000656570 | SCV005263953 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Department of Pathology and Laboratory Medicine, |
RCV000192476 | SCV000592483 | benign | not specified | no assertion criteria provided | clinical testing | The MSH2 p.Ala328= variant was identified in 8 of 1632 proband chromosomes (frequency: 0.005) from Italian, Dutch, Australian and Chinese individuals or families suspected of having Lynch syndrome/meeting Amsterdam and/or Bethesda criteria, and was identified in 1 of 346 control chromosomes (frequency: 0.003) from healthy individuals (Pastrello_2011_21239990, Yap_2009_18726168, Curia_1999_10446963, Lee_2005_15996210, Scott_2001_11112663, Overbeek_2007_17453009, Samowitz_2001_11606497). The variant was also identified as a somatic mutation in a study of sporadic colon tumors of Hungarian patients (Kamory 2003). In 1 proband with an MSI+/ hypermethylation negative, IHC intact tumour, germline analysis identified the variant co-occurring with an unclassified variant c.250A4G (p.Lys84Glu) in MLH1 (Overbeek_2007_17453009), and in another study with a pathogenic MSH2 variant (c.942+2T>A) (Pastrello_2011_21239990). The variant was identified in the following databases: dbSNP (ID: rs4987189) “With Likely benign, other allele”, ClinVar (classified likely benign, reviewed by an expert panel (2013); submitters: benign by GeneDx, Invitae and Prevention Genetics, and likely benign by InSIGHT, Ambry Genetics, and Illumina), Clinvitae (3x), Cosmic (1x in a carcinoma of the large intestine), UMD-LSDB (6x as neutral, co-occurring with pathogenic variants MSH6 (c.2455G>T/p.Glu819X), and MLH1 (c.1489delC/ p.Arg497GlyfsX11, c.121G>C/p.Asp41His), Insight Colon Cancer Gene Variant Database (16x as class 2), Mismatch Repair Genes Variant Database (8x), Insight Hereditary Tumors Database (18x), and in control databases in 1270 (26 homozygous) of 277190 chromosomes at a frequency of 0.005 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). Breakdown of the observations by population include Other in 22 of 6468 chromosomes (freq: 0.003), Latino in 95 (1 homozygous) of 34416 chromosomes (freq: 0.003), European Non-Finnish in 212 of 126682 chromosomes (freq: 0.002), Ashkenazi Jewish in 8 of 10152 chromosomes (freq: 0.0008), East Asian in 2 of 18868 chromosomes (freq: 0.0001), European Finnish in 5 of 25786 chromosomes (freq: 0.0002), and South Asian in 926 (25 homozygous) of 30782 chromosomes (freq: 0.03). The variant was not identified in GeneInsight-COGR, MutDB, or Zhejiang Colon Cancer Database. The variant was also identified by our laboratory in 4 individuals with colon cancer. 1 pos case variant cooccurred with pathogenic msh2 mutation c.942+2T>Apos case malyasianunrelated healthy controls. The p.Ala328= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. | |
Diagnostic Laboratory, |
RCV000613302 | SCV000734198 | likely benign | Lynch syndrome 1 | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000613302 | SCV000745636 | likely benign | Lynch syndrome 1 | 2015-08-21 | no assertion criteria provided | clinical testing | |
Mayo Clinic Laboratories, |
RCV000656570 | SCV000778617 | likely benign | not provided | 2017-12-18 | no assertion criteria provided | clinical testing | |
True Health Diagnostics | RCV000126809 | SCV000805271 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-29 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000192476 | SCV001918443 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000192476 | SCV002034119 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000192476 | SCV002036625 | benign | not specified | no assertion criteria provided | clinical testing |